CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-03 | Zoth Lota S. Director | Grant or award · Restricted Stock Unit | +12,270 | 12,270 | ||
| 2018-12-06 | DHILLON AVTAR S Director | Exercise or conversion | +25,000 | $2.00 | $50K | 106,002 |
| 2018-12-06 | DHILLON AVTAR S Director | Exercise or conversion · Common Stock Options | −25,000 | 0 | ||
| 2018-12-05 | YARNO WENDY L Director | Exercise or conversion | +4,090 | 4,090 | ||
| 2018-12-05 | YARNO WENDY L Director | Exercise or conversion · Restricted Stock Unit | −4,090 | 8,180 | ||
| 2018-11-29 | KIES PETER CFO | Exercise or conversion | +10,001 | $2.00 | $20K | 72,089 |
| 2018-11-29 | KIES PETER CFO | Sale | −10,001 | $5.28 | $53K | 62,088 |
| 2018-11-29 | KIES PETER CFO | Exercise or conversion · Common Stock Option | −10,001 | 0 | ||
| 2018-09-12 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +49,060 | $5.08 | $249K | 2,357,554 |
| 2018-09-12 | Kim Jong Joseph Chief Executive Officer | Sale | −49,060 | $5.37 | $263K | 2,308,494 |
| 2018-09-12 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Common Stock Option | −49,060 | 0 | ||
| 2018-07-10 | KIES PETER CFO | Sale | −10,000 | $4.45 | $45K | 62,088 |
| 2018-07-09 | KIES PETER CFO | Exercise or conversion | +15,000 | $4.24 | $64K | 97,088 |
| 2018-07-09 | KIES PETER CFO | Sale | −25,000 | $4.43 | $111K | 72,088 |
| 2018-07-09 | KIES PETER CFO | Exercise or conversion · Common Stock Option | −15,000 | 0 | ||
| 2018-05-12 | Weiner David B. Director | Exercise or conversion | +7,669 | 766,625 | ||
| 2018-05-12 | Weiner David B. Director | Exercise or conversion · Restricted Stock Unit | −7,669 | 0 | ||
| 2018-05-12 | Cabrera Angel Director | Exercise or conversion | +7,669 | 59,419 | ||
| 2018-05-12 | Cabrera Angel Director | Exercise or conversion · Restricted Stock Unit | −7,669 | 0 | ||
| 2018-05-12 | MAHMOUD ADEL Director | Exercise or conversion | +7,669 | 22,669 |
Page 38 of 49 · 961 trades